Evidence map›Paper›PMID 37274921›Full record

ReviewAsian journal of pharmaceutical sciences2023

Additive manufacturing of sustainable biomaterials for biomedical applications.

Zia Ullah Arif, Muhammad Yasir Khalid, Reza Noroozi, Mokarram Hossain, HaoTian Harvey Shi, Ali Tariq, Seeram Ramakrishna, Rehan Umer

Abstract readReview
In one paragraph

Review in Asian journal of pharmaceutical sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Journal of pharmaceutical analysis · 2024
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Zia Ullah ArifDepartment of Mechanical Engineering, University of Management & Technology Lahore, Sialkot Campus 51041, Pakistan.
Muhammad Yasir KhalidDepartment of Aerospace Engineering, Khalifa University of Science and Technology, Abu Dhabi 127788, United Arab Emirates.
Reza NorooziSchool of Mechanical Engineering, Faculty of Engineering, University of Tehran, Tehran, Iran.
Mokarram HossainZienkiewicz Centre for Computational Engineering (ZCCE), Faculty of Science and Engineering, Swansea University, Swansea SA1 8EN, UK.
HaoTian Harvey ShiDepartment of Mechanical & Materials Engineering, Western University, Ontario N6A 3K7, Canada.
Ali TariqDepartment of Mechanical Engineering, University of Management & Technology Lahore, Sialkot Campus 51041, Pakistan.
Seeram RamakrishnaDepartment of Mechanical Engineering, Center for Nanofibers and Nanotechnology, National University of Singapore, 119260, Singapore.
Rehan UmerDepartment of Aerospace Engineering, Khalifa University of Science and Technology, Abu Dhabi 127788, United Arab Emirates.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Biopolymers are promising environmentally benign materials applicable in multifarious applications. They are especially favorable in implantable biomedical devices thanks to their excellent unique properties, including bioactivity, renewability, bioresorbability, biocompatibility, biodegradability and hydrophilicity. Additive manufacturing (AM) is a flexible and intricate manufacturing technology, which is widely used to fabricate biopolymer-based customized products and structures for advanced healthcare systems. Three-dimensional (3D) printing of these sustainable materials is applied in functional clinical settings including wound dressing, drug delivery systems, medical implants and tissue engineering. The present review highlights recent advancements in different types of biopolymers, such as proteins and polysaccharides, which are employed to develop different biomedical products by using extrusion, vat polymerization, laser and inkjet 3D printing techniques in addition to normal bioprinting and four-dimensional (4D) bioprinting techniques. This review also incorporates the influence of nanoparticles on the biological and mechanical performances of 3D-printed tissue scaffolds. This work also addresses current challenges as well as future developments of environmentally friendly polymeric materials manufactured through the AM techniques. Ideally, there is a need for more focused research on the adequate blending of these biodegradable biopolymers for achieving useful results in targeted biomedical areas. We envision that biopolymer-based 3D-printed composites have the potential to revolutionize the biomedical sector in the near future.

Indexed as

3D printingAdditive manufacturingBiomedicalBiopolymersSustainable biomaterialsTissue engineering

Identifiers

PMID37274921
PMCPMC10238852

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.